Clinical Trial Update: Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 2/Phase 3 clinical trial evaluating arsenic trioxide delivered via transarterial chemoembolization (TACE) and by intraveno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Carcinoma, Hepatocellular | Phase 2, Phase 3 | Status: UNKNOWN